chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Day three after vax: Swollen tender lymph node left neck, Headache over left eye, pain left cheekbone,  Day five after vax: sinus infection, fatigue.  Treated with nasal lavage, antihistamine, tylenol. Signs of infection resolved after one week.  Headache over left eye and pain in left cheekbone and teeth have not resolved. Lymph node left neck remains tender/enlarged. Taking Tylenol daily. For these symptoms throughout the month of October (took a home COVID test twice in October, both were negative. On November 8 headache on left side worsened, developed symptoms of trigeminal neuralgia (severe pain radiating to eyebrow, upper and lower jaw areas, teeth aching, pain triggered by chewing, hot, cold).  Had itchy and sore pimples at left eyebrow, left earlobe, and jaw line. Sore area in gums over teeth on left side in mouth. Suspicious for shingles. I am vaccinated with Shingrix.  Pain is easing up but still present at time of submission.
Myalgia, Arthralgia, Diarrhea,  Injection site pain; chills; fatigue Narrative:
rash around left shoulder and down left arm, soreness and unable to lay on it or lift it
stroke; This is a spontaneous report from a contactable Pharmacist, the patient's daughter-in-law.  An 84-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 05Feb2021 (at the age of 84-years-old) as a single dose for COVID-19 vaccination. Medical history included stroke and atrial fibrillation from unknown dates. Concomitant medications were not reported. On 12Feb2021, the patient experienced a stroke. The clinical outcome of the event stoke was unknown. No additional information was reported.   Information about lot/ batch number has been requested.
Narrative: Pt is a 75y.o. male who died on 04/24/2021 w/ h/o HLD, PVD, T2DM, CAD, Glaucoma. Pt received Moderna Covid-19 vaccine 2/2 on 02/22/2021. Unlikely that Moderna Covid-19 vaccine caused/contributed to pt death.
diagnosis swollen lymph nodes; Pronounced swelling at neck on left side starting 4 days post vaccination; This is a spontaneous report from a contactable consumer (patient). A 43-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: ER8729) via an unspecified route of administration on 05Apr2021 at 10:45 (at the age of 43-years-old) in left arm as a single dose for covid-19 immunization. Medical history included aortic aneurysm from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the covid vaccine. Prior to vaccination, the patient was not diagnosed with covid-19. Since the vaccination, the patient had not been tested for covid-19. The patient had no allergies to medications, food, or other products. The patient's concomitant medications received within 2 weeks of vaccination were reported as none. The patient's historical vaccine included first dose of BNT162B2 (COVID Pfizer vaccine; lot number: EN6207) on 14Mar2021 at 10:45 for covid-19 immunization. The patient experienced pronounced swelling at neck on left side starting 4 days post vaccination on 09Apr2021 and swollen lymph nodes on an unspecified date. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient was recommended ibuprofen. The outcome of both the events was unknown.  No follow-up attempts are needed. No further information is expected.
Site: Pain at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Allergic: Anaphylaxis-Severe, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fever-Medium, Systemic: Weakness-Severe, Additional Details: Pt. said the shot was administered really high on her left arm and was very painful.  She said that a couple of hours after receiving the vaccine she was dizzy, weak, had a fever, and her left arm was very swollen.  She went to the ER where she said she experienced anaphylaxis (throat closing in) and was told a blood vessel might have been hit during administration causing the reaction.
Rash and burning sensation on forehead, eye lids, under eye, cheeks, and under chin/neck area. I washed my face like regular night routine (cerave, vitamin e oil, and ointment cream for acne) and it seemed to irritate it more.   Headaches; first time inthe for front of my head then moved to the back of my upper neck. Tylenol was the chosen treatment. No noted outcome yet.
Information has been received from a mother concerning her son who was vaccinated with MMR II and subsequently, the pt "was dx'd as being autistic". Upon internal review, autism was considered an "Important Medical Event". Additional information has been requested. FU info from the physician indicated that she was "unaware of a patient has been diagnosed with autism after receiving the MMR vax.  Follow up on 03/28/2001: "Patient date of birth, patient age at time of vaccination, adverse event onset date/time, Lot # for vaccine 1, vaccine administration date/time is not provided."
Information has been received from a physician and a registered nurse (R.N.) concerning a 5-year-old female with no pre-existing allergies, birth defects, or medical conditions, who on 25-JUL-2006 at 10:00 was vaccinated subcutaneously with a second dose of Varivax (lot# 646538/0783R). There was no illness at the time of vaccination. On 19-AUG-2006 the patient developed chickenpox. Unspecified medical attention was sought and the chicken pox were described as moderate to severe and the size of an eraser tip with hard whit pustules. They started on the patient's trunk and moved to the ankles, arms, legs, arm pits, and vaginal area. The patient also experienced a low grade temperature. No laboratory or diagnostic tests were performed. Subsequently, the patient recovered from chickenpox on 25-AUG-2006. No product quality complaint was involved. Additional information is not expected.
Received Flu and Pneumovax around 2:30 pm.  That night awoke to pain in Pneumovax arm with swelling from shoulder to elbow, temperature 102, couldn't move due to pain.  Pain was "shooting"up neck and down side.  Went to the ER the next day as symptoms worsened.  ER gave her IV fluids/antibiotics and sent home.  Her regular physician was seen on Monday with no new treatment.  Over the course of her symptoms, she had taken ADVIL and TYLENOL.  As of 11-14-06 states her temperature is now 99.9 and her arm is still warm to touch and painful but the "swelling" has gone down.
The adverse started a week after the vaccine heart rate was extremely high and would end up with chest pain. Went to the emergency room four times. Heart rate kept getting high every day and stated she couldn't figure out what was going on and the hospital told her that she was having panic attacks but participant feels it was much more.
cold sweats still occurring going into day 3; very excessive amount of sweating soaking through clothes sheets, comforters; Debilitating consistent headache; light sensitivity as well as continuous double vision; light sensitivity as well as continuous double vision; Muscle pain like sand paper; sharp joint pain; loss of appetite and cognitive function; loss of appetite and cognitive function; Fever first night and next day off and on no higher that 101.3; This is a spontaneous report from a contactable consumer (Patient). A 32-year-old male patient received bnt162b2 (BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 19Feb2021 06:15 AM (Batch/Lot number was not reported) as DOSE 2, SINGLE (at the age of 32-year-old) for covid-19 immunisation. The patient medical history was not reported and had no allergies. Historical vaccine included BNT162B2 dose 1 for covid-19 immunization on an unknown date. There were no concomitant medications. The patient did not receive other vaccine in four weeks. The patient did not receive other medications in two weeks. On 19Feb2021 14:00, patient experienced loss of appetite and cognitive function. Fever first night and next day off and on no higher than 101.3, cold sweats still occurring going into day 3, very excessive amount of sweating soaking through clothes sheets, comforters, debilitating consistent headache, light sensitivity as well as continuous double vision, muscle pain like sand paper, sharp joint pain. Patient did not receive treatment for adverse events. On 19Feb2021, patient underwent lab tests which included body temperature: 101.3. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. Outcome of evets was reported as recovering.    No follow-up attempts are possible; information about lot/batch number cannot been obtained.
16JUL-18JUL temp varied 101-105 R reported by mom retained fluids well; ckd w/MD office several times & cont to give Pandol; 18JUL seen by MD; viral synd or rxn to inject;
Warm, red rash on chest, stomach, upper back shoulder area, back of neck, and upper back area.
itching of injection site; red mark on injectionsite; headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching of injection site), VACCINATION SITE ERYTHEMA (red mark on injectionsite) and HEADACHE (headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itching of injection site), VACCINATION SITE ERYTHEMA (red mark on injectionsite) and HEADACHE (headache). At the time of the report, VACCINATION SITE PRURITUS (itching of injection site), VACCINATION SITE ERYTHEMA (red mark on injectionsite) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details was not reported by the reporter.
Onset of bad body/joint aches about 20 hrs post-vaccine, worsening for about 6-7 hours and dissipating over following 2 hours.
Experienced itching at injection site, immediately after vaccine #1, lasting for 5 days.   Experienced headache, chills, and muscle aches for approximately 48 hours following vaccine dose #2. Headache, chills, and fatigue, with muscle aches in lower back and hips began approximately 5 hours after vaccine and diminished after three days.  Treated symptoms with 2 Advil gel tablets, every 4 hours for 48 hours total.   No itching at the injection site after vaccine #2.
Swollen lymph nodes; stiff joints; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 51-year-old patient received BNT162b2 (COMIRNATY), as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 51 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series complete; unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (1st Booster dose, Batch/Lot: Unknown), for COVID-19 immunization. The following information was reported: LYMPHADENOPATHY (non-serious), outcome "unknown", described as "Swollen lymph nodes"; JOINT STIFFNESS (non-serious), outcome "unknown", described as "stiff joints".  Additional information: Event took place after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Woke up feeling very flu like. Couldn't stay awake and slept most of the day. My husband went and got me OTC cold and flu meds that helped. Had cough, congestion, sore throat, and body aches. Symptoms continued and I slept most of the day. Took at home COVID-19 on Thursday and it was negative. Retested on Monday and it was positive. Called PCP after positive COVID-19 test and she prescribed Z-PAK and steroids. Didn't notice any real difference after beginning those drugs. Symptoms have mostly resolved except for nasal congestion and drainage.
PATIENT PRESENTED TO THE PHARMACY ON SATURDAY (11/11) AND WAS NOT FEELING WELL AND HIS ARM WAS HURTING AND BURNING AND THE PHARMACIST ON DUTY CALLED 911 TO HAVE HIM TAKEN TO THE EMERGENCY ROOM. HE PRESENTED BACK TO THE PHARMACY ON 11/12 WITH TWO PRESCIPTIONS, ONE FOR BACTRIM AND ONE FOR KEFLEX. HE SAID THE DOCTOR SAID HE HAD CELLULITIS.
mom called 245Pm day of vax to report pt had swollen lt thigh w/red streaks, felt warm & a high pitched cry; RN reported hearing a fussy baby; mom was advised to start APAP & use cold compresses;
Significant, constant, pain in her left arm since the flu shot. Pain was exacerbated by lying in bed in certain positions and when moving or doing certain things, such as pushing or pulling (up her socks, for example). Even touch exacerbated her pain.  She was diagnosed with with post-vaccine bursitis and received a cortisone injection on 12/21/2021.
Patient said she tastes the medicine in her mouth. I told her have a seat she started feeling itchy throat, tingling mouth and burning between gums and lips. I gave her 50 mg/ml injection Benadryl and took vitals every 15 minutes. No problem breathing.
p/vax pt devel redness; edema & tenderness approx 1'' below the inj site; seen by MD
Patient reported being paralyzed in the middle of the night the night after vaccination. Parent did not witness event, as child could not call out for parent during paralysis episode. Patient has not had any episodes since, and parent has been checking on her each night.
3 friends got COVID-19 infection after completing the Moderna COVID-19 primary series because their immunity went down.; people who have gotten the Moderna COVID-19 vaccine earlier on in the; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (3 friends got COVID-19 infection after completing the Moderna COVID-19 primary series because their immunity went down.) and MALAISE (people who have gotten the Moderna COVID-19 vaccine earlier on in the) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (3 friends got COVID-19 infection after completing the Moderna COVID-19 primary series because their immunity went down.) and MALAISE (people who have gotten the Moderna COVID-19 vaccine earlier on in the). At the time of the report, COVID-19 (3 friends got COVID-19 infection after completing the Moderna COVID-19 primary series because their immunity went down.) and MALAISE (people who have gotten the Moderna COVID-19 vaccine earlier on in the) outcome was unknown.            No concomitant medications reported by reporter No treatment medications provided by the reporter.   Caller reported three friends have come down with COVID-19 infection after completing the Moderna COVID-19 primary series because their immunity went down. She also reported the Moderna vaccine does not provide any long-term protection against COVID-19. The caller also stated that people who have gotten the Moderna COVID-19 vaccine earlier on in the year are now getting sick because their antibodies are dropping.  This is a spontaneous case concerning an unknown years old, unknown gender patient with unknown clinical history who experienced the unexpected events of COVID-19 (AESI) and MALAISE. The events occurred unknown days after the first dose of mRNA-1273 vaccine. The rechallenge is not applicable as the events occurred after the first dose and no more doses will be received by the patient.The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case concerning an unknown years old, unknown gender patient with unknown clinical history who experienced the unexpected events of COVID-19 (AESI) and MALAISE The events occurred unknown days after the first dose of mRNA-1273 vaccine The rechallenge is not applicable as the events occurred after the first dose and no more doses will be received by the patient  The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Burning sensation in left hand fingertips; Achy; numbness sensation in left hand fingertips; Swollen lymph nodes in left armpit; Tired; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Burning sensation in left hand fingertips), PAIN (Achy), HYPOAESTHESIA (numbness sensation in left hand fingertips), LYMPHADENOPATHY (Swollen lymph nodes in left armpit ) and FATIGUE (Tired) in a 61-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2021, the patient experienced BURNING SENSATION (Burning sensation in left hand fingertips), HYPOAESTHESIA (numbness sensation in left hand fingertips) and LYMPHADENOPATHY (Swollen lymph nodes in left armpit ). December 2021, the patient experienced PAIN (Achy) and FATIGUE (Tired). In December 2021, BURNING SENSATION (Burning sensation in left hand fingertips), PAIN (Achy), HYPOAESTHESIA (numbness sensation in left hand fingertips), LYMPHADENOPATHY (Swollen lymph nodes in left armpit ) and FATIGUE (Tired) had resolved.            No concomitant medication information was provided. No treatment medication were provided.
Pt received vaccination from our facility on 10/16/21 at 2:30pm and she developed adverse reactions of chills and malaise on 10/17/21. on 10/18/21 she developed a stoke.
Patient complained of stomach pain and headache that began the same night as the vaccine and has continued for 1 week.  After one week patient c/o Nausea as well.
Patient presented to the ED for closed fraction dislocation of left ankle on 5/30/2021. Patient was hospitalized on 6/8/2021 for hospice/palliative care. Patient hospitalized on 6/9/2021 for open reduction internal fixation left trimalleolar ankle fracture, medial and lateral malleoli with fixation of the syndesmosis. He died on 6/24/2021. These visits are within 6 weeks of receiving COVID vaccination.
Information has been received from a health professional concerning an approximately 40 year old female with a yeast allergy who "approximately 5 years ago" in approximately 1999, was vaccinated with a first dose of hepatitis B virus vaccine rHBsAg(yeast). It was reported that she had an allergic reaction to the vaccine. It was noted that the first dose was received but no additional doses were given. Medical attention was sought. The patient was considered recovered. No product quality complaint was involved. Additional information is not expected.
Information has been received from a 72 year old female nurse with no medical history who on 26-APR-2007 was vaccinated with 0.65 ml Zostavax (Lot # 656395/0290U). Concomitant therapy included "Cynthorid", Simvastatin and alendronate sodium. On 28-APR-2007 the patient experienced some pain and redness at injection site. Unspecified medical attention was sought. No diagnostic laboratory procedures were performed. A product quality complaint was not involved. No further information is available.
Case number PHEH2014US003668, is an initial spontaneous report from a pharmacist received on 20 FEB 2014. This report refers to a patient of unknown demographics. The patient's medical history and concomitant medications were not reported. This patient under the age of 18 years was vaccinated with FLUCELVAX (batch number: unknown) intramuscularly on 20 FEB 2014. No adverse event was reported following the medication error. No further information was provided.  Following an internal review on 18 AUG 2014, a significant correction was done for the information received on 20 FEB 2014: The BPI labeling of the event "inappropriate age at vaccine administration" changed from listed to unlisted and added second indication as "drug used in unapproved population".
Got PENTACEL, Hep A and PCV13 booster couple hours later local edema, pain w/walking.
Stated she felt "wiped out" and almost passed out approx 1/2 hour after receiving H1N1 vaccine. She then experienced a rash on her face approx 3 days after receiving the vaccine. Itching accompanied the rash.
Pregnant patient received the moderna  vaccine; This spontaneous prospective pregnancy case was reported by a health care professional and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received the moderna  vaccine) in a female patient of an unknown age (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 19-May-2020 and the estimated date of delivery was 23-Feb-2021. On 02-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received the moderna  vaccine). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-seventh week of the pregnancy. The vaginal delivery occurred on 03-Mar-2021, which was reported as Full-term. For neonate 1, the birth weight was 4170 grams (9lbs 3oz) with an APGAR score of 8 and 10 at (1, 5 minutes). The outcome was reported as Term Birth NOS. Baby's head was stuck and doctor had to use vacuum to help deliver him. Perinatal complications include JAUNDICE.. Male baby(Infant) length is 54.6cm, Head circumference is 45.7cm. On 02-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received the moderna  vaccine) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Jun-2020, Pregnancy test: positive (Positive) positive. On 20-Jul-2020, Blood test: normal (normal) normal. On 20-Jul-2020, Ultrasound scan: pregnant (Inconclusive) Pregnant. On 03-Dec-2020, Glucose tolerance test: 164 (High) 164. On 09-Dec-2020, Glucose tolerance test: 159,141, 165, 83 (Inconclusive) 159,141,165,83.. On 02-Mar-2021, Ultrasound scan: meconium in amniotic sac (Inconclusive) Meconium in amniotic sac..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided. Medical history of the patient included-Maternal Grandma (Arthritis), Paternal Grandma (Arthritis, Glaucoma), Paternal Grandpa (Stroke).   This case was linked to MOD-2021-080805 (Parent-Child Link).   See case MOD-2021-080805 for details regarding the child case.
PATIENT RECEIVED INFLUENZA VACCINE INTRAMUSCULAR LEFT DELTOID ON 10/17/2006.  PATIENT REPORTS HAVING A "ITCHY THROAT" AND "SWELLING OF THE TONGUE" A FEW HOURS AFTER VACCINATION.  LATER IN THE EVENING, THE PATIENT EXPERIENCED HIVES ON CHEST, BACK, LEGS, ARMS, NECK, AND FACE.  CONTACTED THEIR DAUGHTER WHICH IS A NURSE AND THE EMERGENCY LINE AT THE LOCAL HOSPITAL WHICH SUGGESTED TAKING BENADRYL.  TALKED WITH PATIENT ON 10/18/2006 CONCERNING REACTION WHICH STATED A DECREASE IN HIVES.  HE PLANS TO CONTINUE TAKING BENADRYL.  STRONGLY SUGGESTED HE FOLLOW UP WITH PRIVATE MEDICAL DOCTOR OR CLINIC.